Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2010
12/01/2010CN101474196B Flavone active site of Vernonia cinerea as well as preparation method and use thereof
12/01/2010CN101385764B Use of snow ganoderma lucidum total saponin in preparing analgesic medicine
12/01/2010CN101347524B Chinese medicinal composition for treating depression and preparation thereof
12/01/2010CN101292994B Method for relieving or neutralizing the effect of alcohol, and products thereof
12/01/2010CN101288671B Use of Triperugium wilfordii monomeric compound for increasing gene expression efficiency mediated by adeno-associated virus vector and subsidiarily treating neurodegenerative disease
12/01/2010CN101269185B Method for preparing traditional Chinese medicine for treating heart-spleen deficiency type depressive psychosis
12/01/2010CN101264256B Chinese medicine capsule for treating intractable pain
12/01/2010CN101224208B Uses of tandospirone and derivative thereof in improving memory and cognitive uses
12/01/2010CN101220063B Novel method for preparing catalpol, medicament composition containing the same and uses thereof
12/01/2010CN101193898B Novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3H)-one derivatives
12/01/2010CN101193897B Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives
12/01/2010CN101168024B Proprietary Chinese medicine for treating depression and production method thereof
12/01/2010CN101133827B Application of ackfruit extract in the aspect of relieving or neutralizing the effect of alcohol
12/01/2010CN101095698B Use of Clostridium Butyricum for preventing and treating foetid faeces toxin syndrome and disease
12/01/2010CN101077154B Drunkenness-dispelling and liver-protecting bean product and its manufacturing method
12/01/2010CN101054572B Method for cultivating human umbilical blood stem cell and directionally differentiating the same to dopaminergic nerve cell and application for the obtained dopaminergic nerve cell
12/01/2010CN101028474B Method for inspecting the quality of Chinese preparation with Yang-and kidney tonifying functions
12/01/2010CN101007035B Application of notoginseng glycol saponins for treating memory deterioration
11/2010
11/30/2010US7842808 Anti-migraine spirocycles
11/30/2010US7842718 thiophene sulfonamide derivatives such as 5-Chloro-N-[(S)-2-hydroxy-1-phenylethyl]thiophene-2-sulfonamide, that inhibit the production of beta amyloid protein from amyloid precursor protein; capable of passing through the blood-brain barrier, used for treatment of Alzheimer's disease and Down's syndrome
11/30/2010US7842699 administering 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or salts, for the treatment of dermatitis, Crohn's disease, inflammatory bowel disease, transplant rejection, lupus, multiple sclerosis, arthritis, psoriasis, diabetes and autoimmune diseases
11/30/2010US7842698 Autoimmune diseases; antiinflamamtory agents, cardiovascular disorders; neurodegenerative diseases, kidney diseases, anticancer agents; platelet aggregation
11/30/2010US7842690 Cyclic hydroxylamine as psychoactive compounds
11/30/2010US7842689 Cyclic hydroxylamine as psychoactive compounds
11/30/2010US7842686 Calcitonin gene-related peptide (CGRP) receptor antagonists, such as 2-(2-Butyl-3-oxo-2H-benzo[b][1,4]thiazin-4(3H)-yl)-N-(2,5-dioxo-1',3'-dihydrospiro[imidazolidine-4,2'-indene]-5'-yl)acetamide, used as analgesics
11/30/2010US7842684 Diphenylazetidinone derivatives possessing cholesterol absorption inhibitor activity
11/30/2010US7842683 Beta-lactam antibiotics and beta-lactamase inhibitors provide significant neurotropic effects in warm-blooded vertebrates evidenced inter alia by anxiolytic and antiaggressive behavior modification and enhanced cognition
11/30/2010US7842677 use in the field of neuroprotection and cancer treatment (neuroblastoma tumors)
11/30/2010US7842501 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/30/2010US7842311 for oral dosage; for treatment of pain; sustained release
11/30/2010US7842309 Tamper-resistant oral opioid agonist formulations
11/30/2010CA2624621C Pyrazine derivatives
11/30/2010CA2607499C Histamine-3 receptor antagonists
11/30/2010CA2497444C Pyrazolopyrimidines as cyclin dependent kinase inhibitors
11/30/2010CA2477208C Substituted phenylalkanoic acid derivatives and use thereof
11/30/2010CA2456817C Alkyne-aryl-naphthyridin-4 (1h)-one derivatives as type iv phosphodiesterase inhibitor
11/30/2010CA2449352C Nsaid formulation comprising a granular composition and an extra-granular composition
11/30/2010CA2440218C Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
11/30/2010CA2430772C Humanized antibodies that recognize beta amyloid peptide
11/30/2010CA2396129C Method and formulation for treating resistance to antihypertensives and related conditions
11/25/2010WO2010135610A2 Cell therapy for brain tissue damage
11/25/2010WO2010135560A1 Modulators of 5-ht receptors and methods of use thereof
11/25/2010WO2010135493A2 Alzheimer's disease imaging agents
11/25/2010WO2010134846A1 Substituted 8-sulfonyl-2,3,4,5-tetrahydro-1h-gamma-carbolines, ligands and pharmaceutical composition; method for the production and use of same
11/25/2010WO2010134814A2 Means and methods for counteracting polyq expansion disorders
11/25/2010WO2010134676A1 Composition comprising the purified extract of bee venom for preventing and treating degenerative brain diseases
11/25/2010WO2010134614A1 SELF-EMULSIFYING COMPOSITION OF ω3 FATTY ACID
11/25/2010WO2010134433A1 Transdermal preparation
11/25/2010WO2010134074A1 Compositions for continuous administration of dopa decarboxylase inhibitors
11/25/2010WO2010133836A1 Fused bicyclic pyrazole derivatives as kinase inhibitors
11/25/2010WO2010133647A1 Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors
11/25/2010WO2010133598A1 Novel pharmaceutically acceptable salts of 4-(1h-imidazol-4-ylmethyl)pyridine and their therapeutical uses
11/25/2010WO2010133569A1 Azabicyclo[4.1.0]heptane derivatives
11/25/2010WO2010133544A1 Piperazine and aminopyrrolidine compounds as histamine h3 receptor antagonists
11/25/2010WO2010133377A1 Fat blends and uses thereof
11/25/2010WO2010133306A1 Process for the preparation of ibodutant (men15596) and related intermediates
11/25/2010WO2010133166A1 Use of paederosidic acid for preparing analgesic and/or anti-inflammatory medicaments
11/25/2010WO2010133016A1 Pharmaceutical composition for treating depression, preparation method and use therefor
11/25/2010WO2010133015A1 Pharmaceutical composition for treating depression and preparative method and use thereof
11/25/2010WO2010132999A1 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
11/25/2010WO2010100650A3 Therapeutic uses of mastic gum fractions
11/25/2010WO2010095940A3 Glutathione-based drug delivery system
11/25/2010WO2010092485A3 Combined treatment of multiple sclerosis
11/25/2010WO2010083203A3 Non-embryonic stem cells and uses thereof
11/25/2010WO2010081034A3 Fluorine containing compounds and methods of use thereof
11/25/2010WO2010071872A3 [2.2.2] bicyclic derivatives and methods of use
11/25/2010WO2010064248A3 Methods of diagnosing and treating motor neuron diseases
11/25/2010WO2010057020A3 Modification of amyloid-beta load in non-brain tissue
11/25/2010WO2010018408A3 Pharmaceutical compositions with tetrabenazine
11/25/2010WO2009137871A8 Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells
11/25/2010US20100299766 Mouse models carrying a knock-out mutation of the qpctl-gene
11/25/2010US20100298735 Methods For Classifying And Treating Physiologic Brain Imbalances Using Quantitative EEG
11/25/2010US20100298561 2-amino-bicyclo(3.1.0) hexane-2, 6-dicarboxylic ester derivative
11/25/2010US20100298528 Cystine knot molecules
11/25/2010US20100298442 1-Amino-alkyl-cyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists
11/25/2010US20100298438 Gene expression profiling of parkinson's disease
11/25/2010US20100298434 Neuroprotection and prevention of dopaminergic cell death by targeting nur77 translocation
11/25/2010US20100298431 Method of improving cognitive functions in individuals with down syndrome and/or alzheimer's disease
11/25/2010US20100298429 stable liquid drug composition comprising carbidopa, and arginine for treating Parkinson's disease; additional including entacapone or tolcapone; long half life; transdermal delivery
11/25/2010US20100298428 Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same
11/25/2010US20100298427 Anti-inflammatory compositions and their use
11/25/2010US20100298426 Therapeutic agent for substance dependence
11/25/2010US20100298425 Use of Tocotrienols for Elevating IKBKAP Gene Expression and Treating Familial Dysautonomia
11/25/2010US20100298423 Nutraceutical composition from garcinia mangostana
11/25/2010US20100298405 Compositions And Methods For Inhibiting Expression Of Huntingtin Gene
11/25/2010US20100298402 Stilbene derivatives as pstat3/il-6 inhibitors
11/25/2010US20100298401 Galenical form for the administration of triptans by buccal transmucous means
11/25/2010US20100298397 Method of treatment of obsessive compulsive disorder with ondansetron
11/25/2010US20100298395 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
11/25/2010US20100298394 Antifungal agents as neuroprotectants
11/25/2010US20100298389 Novel Imaging Tracers for Early Detection and Treatment of Amyloid Plaques Caused by Alzheimer's Disease and Related Disorders
11/25/2010US20100298382 Compositions and methods for alleviating depression or improving cognition
11/25/2010US20100298381 Gamma secretase modulators
11/25/2010US20100298380 N-aryl-n-piperidin-4-ylmethyl-amide derivatives and thier use as monoamine neurotransmitter re-uptake inhibitors
11/25/2010US20100298379 Pharmaceutical compositions of 5-hydroxytryptophan and serotonin-enhancing compound
11/25/2010US20100298376 Use of novel neuroprotective 3-substituted indolone compositions
11/25/2010US20100298375 medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease
11/25/2010US20100298372 Gamma secretase modulators
11/25/2010US20100298359 Gamma secretase modulators
11/25/2010US20100298358 Naphthamide Derivatives As Multi-Target Protein Kinase Inhibitors and Histone Deacetylase Inhibitors
1 ... 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 ... 1833